Observing treatment options for acute ischemic stroke in Southwest China
Registration of Acute Ischemic Stroke With Large and Medium-sized Vascular Occlusion in Southwest China(LMVOS)
This study is tracking 8,000 patients with acute ischemic stroke in Southwest China to see which treatment options work best and how they help people recover over 90 days.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 8000 (estimated) |
| Sex | All |
| Sponsor | The Affiliated Hospital Of Southwest Medical University Academic / other |
| Locations | 1 site (Luzhou) |
| Trial ID | NCT06125236 on ClinicalTrials.gov |
What this trial studies
This observational study aims to register and analyze treatment options for patients with acute ischemic stroke caused by large and medium-sized vascular occlusions. Over a period of 22 years, the study will enroll 8,000 patients to evaluate the safety and efficacy of various treatment strategies in real-world clinical settings. The study will follow patients and assess their outcomes at 90 days post-treatment, providing valuable insights into the management of this condition.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with acute ischemic stroke due to large or medium vessel occlusion.
Not a fit: Patients with acute ischemic stroke not caused by large or medium vessel occlusion may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of effective treatment strategies for acute ischemic stroke, leading to improved patient outcomes.
How similar studies have performed: While this study is observational and focuses on real-world data, similar studies have shown success in understanding treatment outcomes for acute ischemic stroke.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: The clinical diagnosis is acute ischemic stroke with large- or medium- vessel occlusion (the criteria followed the Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018). Informed consent from the patient or surrogate. Exclusion Criteria: No additional exclusion criteria.
Where this trial is running
Luzhou
- Affiliated Hospital of Southwest Medical University — Luzhou, China (Recruiting)
Study contacts
- Study coordinator: Zhengzhou Yuan, MD
- Email: coneuro@163.com
- Phone: +868303165661
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.